Effective Data Management and Integration
Many Venture Capital (VC) and Private Equity (PE) investors focused on biotechnology, biopharmaceutical and other life science verticals have experienced the uncomfortable position of seeing runway running out whilst months are spent collating and preparing regulatory filings which represent a value inflexion point and unlock an opportunity for the next cash injection into the business.
Large pharmaceutical companies, driven by the need for scale and efficiency, are increasingly adopting digitalization and AI-driven approaches to streamline these time-consuming processes. These innovations accelerate time-to-market and significantly reduce R&D and regulatory costs . For example, by integrating AI models, Novo Nordisk reduced the time required to compile regulatory documents from 15 weeks to under 10 minutes—cutting the number of personnel needed from over 50 to just three.
In contrast, VC and PE invested startups often fail to leverage these technologies in a similar way and, as a result, lose competitiveness. Those who embrace the opportunities represented by these technologies will outcompete peers, both in terms of attracting capital and generating returns. The challenges, however, in doing this successfully are significant.
Life science ventures generate an immense volume of complex scientific data—from early-stage research through clinical development. As a result, investors in these companies face both a challenge and an opportunity:
- Challenge: Ensuring that investee companies capture and manage data effectively, abiding by FAIR (Findable, Accessible, Interoperable, and Reusable) principles.
- Opportunity: Unlocking transformative insights and value by leveraging advanced digitalization and data standardization solutions across an investment portfolio.
This white paper highlights why scientific data is a mission-critical digital asset for investors, which is often overlooked, how data synergies drive superior insights, and how SciY’s solutions for automated information extraction from analytical data and for digitalization, standardization, and AI readiness provide a pathway to maximize data value and business development across a portfolio.
